查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2138497

2D和3D一次性生物製程袋市場報告：趨勢、預測和競爭分析（至2035年）

2D and 3D Single Use Bioprocess Bag Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2D和3D一次性生物製程袋市場

全球2D和3D一次性生物製程袋市場前景廣闊，主要得益於緩衝液/培養基、原液儲存和中間體儲存市場的發展機會。預計到2035年，全球2D和3D一次性生物製程袋市場規模將達到256億美元，高於2027年的76億美元，2027年至2035年的年複合成長率（CAGR）為14.3%。推動市場成長的關鍵因素包括醫療保健領域的投資增加、一次性生物製程技術的廣泛應用以及生物製藥需求的成長。

  • 根據 Lucintel 的預測，由於對高性能材料的需求不斷成長，EVA 預計將在預測期內呈現最高的成長率。
  • 按應用領域來看，「緩衝液和培養基」預計將在整個預測期內呈現最高的成長率，這是因為對高效能儲存的需求不斷成長。
  • 從區域來看，受生物技術領域投資增加的推動，亞太地區預計將在預測期內呈現最高的成長率。

2D和3D一次性生物製程袋市場的新趨勢

2D和3D一次性生物製程袋市場正從簡單的流體容器轉向支持先進生物製藥生產的工程系統。預計在2025年至2027年間，製造商將專注於細胞和基因治療的性能、速度、供應鏈彈性和靈活的包裝形式。 Lucintel認為，相關設施日益成長的需求將推動技術差異化。

  • 永續性：供應商正在公佈其包裝袋的永續性數據，並致力於提高包裝袋的產量和使用壽命。賽多利亞斯在2025年報告中概述了對永續性的持續投入，越來越多的產業組織也開始評估一次性塑膠製品。隨著生物製造公司權衡永續性和環境成本，未來三到五年內，客戶將開始轉向更永續的選擇。
  • 自動化：到2027年左右，整合數位控制流程的自動化包裝袋組裝（用於稱重、混合、取樣和無菌連接）將成為優先事項。預計到2027年，感測器輔助組裝和封閉式流程也將納入工廠建設項目中。隨著產量增加，重點將轉向自動化，以保持記錄的一致性和準確性，從而進一步減少人工干預。
  • 尖端材料：萃取和浸出物（E&L）測試、改進的焊接工藝以及先進的多層薄膜的結合，將持續擴大一次性包裝袋的應用範圍。領先的供應商將繼續對薄膜合格，使其適用於約-80 度C至室溫的儲存溫度範圍（2025年至2027年）。材料技術的進步將確保一次性包裝製程的安全性，並防止重新採用更複雜的系統。
  • 細胞和基因療法的個人化：對小批量生產和更個性化療法的需求日益成長，將催生對高度專業化的輸液袋和輸液管的更大需求。預計2025年，全球將進行數千項細胞和基因療法臨床試驗。能夠減少製程步驟並最大限度減少材料浪費的靈活小批量生產系統將變得至關重要，這將迫使製造商重新思考其產品設計。
  • 按地區實現供應鏈多元化：製藥公司正在北美、歐洲和亞洲範圍內合格薄膜、組件和組裝的二級供應商。有關2025年產能的公告表明，對當地生物加工產業的投資將持續進行。由於供不應求、貿易挑戰和合格問題正在擾亂計劃庫存需求，因此供應多元化勢在必行。

未來三年，2D和3D一次性生物製程袋的主要競爭因素將是驗證的完整性、薄膜性能、供應穩定性以及生命週期資料。雖然生物製藥領域預計需求最為強勁，但細胞和基因治療領域將提出更具體的要求。市場領導者將把標準化平台與特定應用工程結合，提供預先設計、可快速切換的系統，以應對跨多個司法管轄區且監管要求各異的生產系統所面臨的挑戰。

2D和3D一次性生物製程袋市場的最新趨勢

隨著生物製藥企業致力於建立靈活的生產能力並降低清潔要求，預計從現在到2025-2027年，2D和3D一次性生物製程袋市場將更加活躍。 Lucintel預測，市場將更加關注更大容量的包裝袋、更堅固的薄膜、更先進的感測器以及區域供應保障。生物製藥、細胞和基因治療以及契約製造的商業化將是市場關注的焦點。

  • 擴大產能：賽多利亞公司於2025年擴大了其生物製程生產能力，目前已能滿足客戶對「Flex Safe」袋及相關框架的需求（2025年1月）。大型區域性設施的投產將有助於客戶縮短各生產基地一次性系統標準化的前置作業時間。
  • 技術拓展：2025年，Salmon Fisher Scientific推出了新型裝袋組件和整合式感測器，旨在為客戶提供更先進的製程控制和更短的換型時間。 （2025年3月）
  • 策略聯盟：Cytiva 與一家領先的生物製藥客戶於 2025 年深化了在高效一次性系統和整合流體管理系統方面的合作。 （2025 年 6 月）
  • 在地化生產：2025年，默克繼續投資於在地化、靈活的一次性用品生產，重點提升其歐洲和北美客戶的供應鏈韌性（2025年9月）。本地化生產有助於緩解供應鏈中斷以及與特種零件短缺和出口限制相關的擔憂。
  • CDMO業務成長：到2025年，CDMO將擴大一次性生物反應器和製劑的生產能力，並新建基於2D和3D袋式平台的設施（預計於2025年11月完工）。 CDMO設施的擴張意義重大，因為它表明對生物反應器袋、導管、連接器和備用部件的需求將持續成長。

未來五年，業界將越來越重視那些能夠以具有競爭力的價格提供品質穩定的薄膜、數據提取、自動化整合以及穩定的區域供應的供應商。同時，對生產損失相關成本的關注度預計也會提高。隨著商業生物製藥的持續成長，那些能夠整合製袋、感測器和組裝，並提供全面服務支援的供應商將獲得最高的利潤率。

目錄

第1章：摘要整理

第2章 市場概覽

  • 背景與分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 全球2D和3D一次性生物製程袋市場：按類型分類

  • 吸引力分析：按類型
  • EVA
  • ULDPE
  • 其他

第5章 全球2D和3D一次性生物製程袋市場：按應用分類

  • 吸引力分析：依目的
  • 緩衝液和培養基
  • 未稀釋溶液的儲存
  • 中間產品的儲存
  • 其他

第6章 區域分析

第7章：北美2D和3D一次性生物製程袋市場

  • 北美2D和3D一次性生物製程袋市場：按類型分類
  • 北美2D和3D一次性生物製程袋市場：按應用領域分類
  • 美國2D和3D一次性生物製程袋市場
  • 墨西哥2D和3D一次性生物製程袋市場
  • 加拿大2D和3D一次性生物製程袋市場

第8章：歐洲2D和3D一次性生物製程袋市場

  • 歐洲2D和3D一次性生物製程袋市場：按類型分類
  • 歐洲2D和3D一次性生物製程袋市場：按應用領域分類
  • 2D和3D一次性生物製程袋德國市場
  • 2D和3D一次性生物製程袋法國市場
  • 西班牙2D和3D一次性生物製程袋市場
  • 義大利2D和3D一次性生物製程袋市場
  • 英國2D和3D一次性生物製程袋市場

第9章：亞太地區2D和3D一次性生物製程袋市場

  • 亞太地區2D和3D一次性生物製程袋市場：按類型分類
  • 亞太地區2D和3D一次性生物製程袋市場：按應用分類
  • 2D和3D一次性生物製程袋日本市場
  • 印度2D和3D一次性生物製程袋市場
  • 中國2D與3D一次性生物製程袋市場
  • 韓國2D和3D一次性生物製程袋市場
  • 印尼2D和3D一次性生物製程袋市場

第10章：2D和3D一次性生物製程袋的全球市場

  • 其他區域2D和3D一次性生物製程袋市場：按類型分類
  • 2D 和 3D 一次性生物製程袋的其他區域市場：按應用領域分類
  • 中東2D與3D一次性生物製程袋市場
  • 南美洲2D和3D一次性生物製程袋市場
  • 非洲2D和3D一次性生物製程袋市場

第11章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析
  • 市佔率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
  • 新趨勢：全球2D和3D一次性生物製程袋市場
  • 戰略分析

第13章：價值鏈中關鍵企業的公司概況

  • Competitive Analysis
  • Cytiva
  • CellBios
  • Entegris
  • Saint-Gobain Life Sciences
  • Sentinel
  • LePure Biotech
  • Cobetter
  • Tofflon
  • Sartorius
  • Biolink

第14章附錄

2D and 3D Single Use Bioprocess Bag Market

The future of the global 2d and 3d single use bioprocess bag market looks promising with opportunities in the buffer & culture medium, stock solution storage, and intermediate product storage markets. The global 2d and 3d single use bioprocess bag market is expected to reach an estimated $25.6 billion by 2035 from $7.6 billion in 2027 with a CAGR of 14.3% from 2027 to 2035. The major drivers for this market are the increase in healthcare investments, the rising adoption of disposable bioprocessing technologies, and the growing demand for biopharmaceuticals.

  • Lucintel forecasts that, within the type category, eva is expected to witness higher growth over the forecast period due to the growing demand for higher-performance materials.
  • Within the application category, buffer & culture medium is expected to witness the highest growth over the forecast period due to the increasing need for efficient storage.
  • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the rising investments in biotechnology sectors.

Emerging Trends in 2D and 3D Single Use Bioprocess Bag Market

2D and 3D Single Use Bioprocess Bag Market is in transition from simple fluid containment toward engineered systems that support the production of intensified biologics. Between 2025 and 2027, manufacturers will be focused on performance, speed, and resilience of the supply chain and flexible formats for cell and gene therapy. Lucintel thinks that facility demands will lead to increased technology differentiation.

  • Sustainability: Suppliers are focusing on improving bag yield and lifecycle while publishing data on bag sustainability; Sartorius revealed its continued investment on sustainability in its 2025 report and more industry organizations are starting to evaluate single-use plastics. suppliers publish. Customers will start shifting to more sustainable options in the next three to five years as biomanufacturers evaluate the trade-offs between sustainability and cost to the environment.
  • Automation: Automated bag assembly with integrated, digitally controlled processes for weighing, mixing, sampling, and aseptic connections will be a focus in the 2027 time frame; sensor-ready assemblies and closed processing will be included in 2027 facility projects. Operator interventions will be further reduced with a focus on automation to retain consistent and accurate records with increased processing volumes.
  • Advanced Materials: Extractables-and-leachable (E&L) testing in combination with improved weld zones and advanced multilayer films will continually increase the applicability of single-use bags; leading suppliers continue to qualify films for storage temperatures from approximately -80°C to ambient conditions in 2025-2027. Material advancements will keep single-use processing safe and prevent a return to more complex systems.
  • Cell and Gene Therapy Customization: The manufacturing of smaller batches and growing demand for more personalized therapies will drive the need for more specialized bags and tubing; by 2025, thousands of cell and gene therapy clinical trials will be underway worldwide. Flexible low-volume manufacturing systems that require fewer steps and minimize material loss will be essential, and manufacturers will have to adjust their product designs.
  • Regional Supply Diversification: Drug manufacturers are qualifying secondary suppliers of film, components, and assemblies across North America, Europe, and Asia; during 2025, capacity announcements showed continued investments in local bioprocessing. Diversification will be necessary as shortages, trade challenges, and qualification issues will disrupt scheduled inventory demands.

For the next 3 years, the main competing factors for 2D and 3D Single Use Bioprocess Bags will be depth of validation, film performance, resilience of supply, and lifecycle data. The strongest demand will be for biologics, however cell and gene therapies will develop more specific requirements. The winners will combine a standardized offering of platforms with application-specific engineering and provide predesigned rapid changeover systems to satisfy the challenges of multi-jurisdictional and spans regulatory production systems.

Recent Developments in the 2D and 3D Single Use Bioprocess Bag Market

Activity in the 2d and 3d single use bioprocess bag market is picking up from now up to 2025-2027 as biopharma manufacturers focus on setting up flexible capacity and decreasing cleaning requirements. Lucintel anticipates greater focus on higher volumes of bags, stronger films, improved sensors, and regional supply assurance. The highest levels of interest are focused on the commercialization of biologics, cell and gene therapies, and contract manufacturing.

  • Capacity Build Out: Sartorius built up its bioprocess manufacturing capacity in 2025 and now meets customer demand for Flex safe bags and related frameworks. (January 2025). Larger regional installations will provide customers shorter lead times to standardize single-use systems across their production sites.
  • Technology Build Out: Thermon Fisher Scientific introduced new bag assemblies and integrated sensors in 2025 to provide customers with greater process control and reduced changeover times. (March 2025)
  • Strategic Partnership: Cytiva and a large biopharma customer deepened their partnership on high impact single use systems and integrated fluid management systems in 2025.(June 2025).
  • Local Production: For 2025, Merck continued to invest in localized flexible single-use manufacturing, focused on supply chain resilience for European and North American customers (September 2025). Local production will help alleviate supply chain disruptions and concerns related to specialized component shortages and export controls.
  • CDMO Growth: Disposable bioreactors and formulation capacity at CDMO's was added in 2025, along with new facilities constructed on a 2D and 3D bag platform (November 2025). The growth of CDMO suites is important as it means continuous demand for bags, tubing, connectors, and spare units.

In the next 5 years, the industry will increasingly favor suppliers that provide consistent films, extractable data, automation integration, and regional supply consistency at a competitive price. There will be a greater emphasis on the cost of lost production. Suppliers that integrate bag manufacturing, sensors, assemblies, and provide complete service support will win the largest margins as commercial biologics continue to grow.

Strategic Growth Opportunities in the 2D and 3D Single Use Bioprocess Bag Market

Manufacturers continue to shift bioprocessing designs between 2024 and 2026 to incorporate more flexible capacity. Faster changeovers and lower exposure to contamination will be included. The demand is beyond the standard cell-culture bags, and there is a need for fit-for-purpose formats for the intensified and/or vaccine production or gene therapy bags. Lucintel predicts that the market will grow even more with single-use technology adoption in smaller facilities and in the emerging markets.

  • Advanced Therapy Applications: Bag suppliers of single-use, 2D or 3D bioprocessing, can modify assemblies designed for use in viral vectors, cell therapies or mRNA workflows. In January 2025, the FDA approved more than 40 cellular and gene therapy products. The demand for closed, disposable, and easy-to-validate systems for the production of small batches will grow.
  • High-performance Premium Bags: Multilayer films with low extractables and strong seals will have higher margins. In April 2025, Sartorius reported that their single-use products for biopharmaceutical manufacturing reach more than 110 countries. In the next 3 to 5 years, these sensitive processes will drive the industry to buy based on performance rather than price.
  • Expanding Into Emerging Markets: The establishment of local inventories and technical support can increase adoption of contract manufacturers in India, Southeast Asia, and Latin America. In February 2025, the Indian Department of Pharmaceuticals recognized 10 focus areas under its biopharmaceutical growth initiative. The growth of regional production will create demand for standardized bags and shorten replenishment cycles.
  • Digital Manufacturing: Disposable plastic bags will become traceable process assets through the use of sensors, serialized components, and electronic batch records. In May 2025, the European Medicines Agency noted that in their reviews of over 25 percent of the advanced therapy applications, complex manufacturing controls were present. Digital traceability will enhance process control, reduce deviations, and improve supplier differentiation during audits.
  • Circularity and Recovery Services: Plastic recycling and take-back programs, along with lower-material designs, can provide new streams of revenue beyond bag sales. In March 2025, the BioPhorum community grew to include more than 150 member organizations focused on biomanufacturing sustainability. Environmental reporting will likely move customers to choose suppliers that quantify waste and provide credible end-of-life options.

Over the next five years, the best margins will accrue to suppliers who integrate advances in film science with application engineering. Growth will not be dictated by bag volume alone. It will be the establishment of central manufacturing with reduced customer qualification time and production support for remote manufacturing, and the extension of service contracts. Companies who localize technical support, improve supply resilience, and document extractable performance will gain long-term market share.

2D and 3D Single Use Bioprocess Bag Market Drivers and Challenges

The 2d and 3d single use bioprocess bag market is a combination of the disruptive force of technology, the booming biopharmaceutical sector along with an equally disruptive economy and evolving regulations. As Lucintel indicates, flexibility, sustainability, and supply-chain resilience, along with the control of contamination, affect adoption. While the market is explosive, limitations in materials, lengthy validation, and the disposal of used bags create challenging conditions to both the manufacturers and users of the bags.

The factors responsible for driving this market include:

  • Increase in Demand for Biopharmaceuticals: The increased production of vaccines, monoclonal antibodies, cell therapies, and recombinant proteins has created demand for single use bags. The majority of the large, global, pharmaceutical companies favor flexible, multiproduct facilities capable of smaller batch production. The approval of 50 new drugs by the U.S. Food and Drug Administration (FDA) in 2025 has increased investment in bioprocessing infrastructure. This driving force will remain active in the next 3 to 5 years. The demand for faster deployment of contamination control systems capable of supporting personalized medicines and biologics will continue to drive the market.
  • Technology Advancements: Developments across multiple technologies, including thin film technologies, high integrity connectors, and sensors along with automation and 3-D bag design, are improving performance and visibility in processes. Advanced bag technologies are able to provide enhanced performance for cell and gene therapy manufacturing and reduce hold-up volumes as well as facilitate better mixing. In 2025, the expected integration of digital bioprocessing platforms with disposable sensors will allow for process monitoring of at least four critical process metrics (temperature, pressure, pH, and dissolved oxygen). Improvements to enable real-time process control, lessen the need for manual intervention, and enhance process consistency and repeatability will facilitate the adoption of single-use technologies for advanced manufacturing in the next 3 to 5 year time frame.
  • Regulatory & Quality Support: Increased flexibility and risk-based thinking concerning single-use technologies has increased single-use technology adoption among biopharmaceutical manufacturers. Increased cohesion in the ICH (International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use) has increased enforcement of regulatory standards with a greater alignment of quality expectations across regulatory members. This increased regulatory cohesion will drive market growth in the next 3 to 5 year time frame as manufacturing suppliers will be able to adopt more consistent documentation and reduce variability in approval requirements.
  • Sustainability & Resource Efficiency: Single-use bags require fewer water resources and cleaning chemical use, and require less validation and instrument downtime compared to reusable stainless-steel systems. When considering energy use, smaller required infrastructure supports less energy use during construction and process operation. Currently, single-use processes require significantly less water per process step than reusable systems due to the reduced need for multiple process cleaning. This trend will continue and be important in the next 3 to 5 years as biopharmaceutical companies make environmental goals. They will also measure the use of resources and work towards more efficient, less burdensome manufacturing.
  • Flexible Manufacturing & Cost Advantages: Disposable bags support quick process changes, minimize risk of cross contamination, and support the production of multiple products in multiple batches with demand production close to the end user. This is beneficial for contract manufacturers, clinical development organizations, and manufacturers producing numerous medical products in demand. In 2025, single-use modular facilities were constructed in < 24 months compared to most multi year traditional construction. Over the next 3 to 5 years, manufacturers will use these modular single-use systems because of the advantage of flexibility with decreased costs for each unit of manufacture and greater product immersion.

The challenges facing this market include:

  • Material and Performance Limitations: Permeability, brittleness, stress cracking, welding defects, and a limited compatibility with harsh chemicals and long process times affect polymer films. Three-dimensional bags must have reliable geometry and minimized flow and mechanical strain. In 2025, a lot of suppliers continued to qualify multilayer films comprising at least three functional layers to balance strength, flexibility and barrier protection. These limitations will have a market impact in the next 3 to 5 years because more demanding processes require improvement in materials, extensive testing, and stronger quality assurance from suppliers.
  • Extractables, Leachables, and Regulatory Validation: Issues with leaching from bags into process streams can impact product safety and affect approval by the regulatory agencies. Resin composition, the impact of sterilization, exposure time, temperature, and process conditions must be evaluated by manufacturers. In 2025, biopharmaceutical validation programs assessed many potential extractable compounds before approving critical single-use assemblies. This will impact the market over the next 3 to 5 years as there will be increasingly sensitive therapies and stricter expectations of quality leading to increased costs, longer qualification periods, and preference toward suppliers with greater analytical ability and demonstrated transparency.
  • Supply-Chain, Waste, and Cost Pressure: Reliance on specialized polymers, films, connectors, and sterilization capacity can create supply shortages, long lead times, and unpredictable pricing. Post-use, bags can become solid waste and require controlled disposal or intensive, energy-consuming waste treatment. In 2025, many manufacturers continued qualifying at least two suppliers for critical single-use components in order to reduce disruption exposure. These factors will affect the market within the next 3-5 years and will lead to increased regional manufacturing, larger buffers of inventory, research towards recycling, and better design with improved efficiencies, but may discourage cost-sensitive manufacturers from adopting the technology.

Flexible production, digital monitoring, and resource-efficient manufacturing reshape biopharmaceutical demand, which will drive the bioprocess single-use bag market in the 2nd and 3rd generations, respectively. Regulatory frameworks and product innovation will support the use of single-use bioprocess bags in clinical and commercial applications. In respective, suppliers who are able to consistently produce films, documents, and bags with sustainable designs, and flexible production, will be able to secure market share. Market success will ultimately depend on a balance of faster, cleaner, and lower cost manufacturing and fulfilling quality, safety, environmental, and operational requirements.

List of 2D and 3D Single Use Bioprocess Bag Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies 2d and 3d single use bioprocess bag market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the 2d and 3d single use bioprocess bag market companies profiled in this report include-

  • Cytiva
  • CellBios
  • Entegris
  • Saint-Gobain Life Sciences
  • Sentinel
  • LePure Biotech
  • Cobetter
  • Tofflon
  • Sartorius
  • Biolink

2D and 3D Single Use Bioprocess Bag Market by Segment

The study includes a forecast for the global 2d and 3d single use bioprocess bag market by type, application, and region.

2D and 3D Single Use Bioprocess Bag Market by Type [Value ($B) from 2019 to 2035]:

  • EVA
  • ULDPE
  • Others

2D and 3D Single Use Bioprocess Bag Market by Application [Value ($B) from 2019 to 2035]:

  • Buffer & Culture Medium
  • Stock Solution Storage
  • Intermediate Product Storage
  • Others

2D and 3D Single Use Bioprocess Bag Market by Region [Value ($B) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the 2D and 3D Single Use Bioprocess Bag Market

Biomanufacturing localization, supply chain investments, and regulatory support are shaping the 2d and 3d single use bioprocess bag market between 2025 and 2027. During this period, suppliers will increase regional production and qualification. According to Lucintel's most recent assessment, such actions will be critical to industry positioning.

  • United States: Domestic biomanufacturing investments continue to grow in the U.S. In April 2025, Resilience was awarded $75 million by the Department of Defense to expand its U.S. based pharmaceutical manufacturing. Cytiva, and other vendors, are continuing to qualify single use systems for Advanced Therapy Medicinal Products (ATMPs). Over the next 3-5 years, investments will enable bag production, decrease the time required to validate, and increase the demand for larger, customized bag assemblies.
  • China: Industrial policies and capacity additions are driving China to localize bioprocessing supply chains. WuXi Biologics reached 135,000 L bioreactor capacity globally in March 2025, and expanded the manufacturing and development capacity in China. Over the medium term, localization will result in domestic sourcing for 2D bags, 3D bags, films, connectors, and integrated assemblies.
  • Germany: Sartorius continues to invest significantly in its German manufacturing, achieving €3.4 billion of 2024 revenue in February 2025 and expanding the single use technology, including bags and assemblies. Through 2030, the entire value chain, including equipment, film, and pharmaceutical manufacturing, strengthens European bag qualification, automation, and export capacities.
  • India: The BioE3 policy (Aug. 2024) offers biomanufacturing support and expands biological production. The Indian government's Department of Biotechnology allocated ₹2,000 crore for the National Biopharma Mission. The policy driven build-out of biomanufacturing should increase adoption of locally sourced baggage as manufacturing capacity for vaccines, biosimilar and cell therapy increases.
  • Japan: The Yokohama expansion of AGC Biologics biomanufacturing facilities occurs in coordination with the identification of a 2,000-liter mammalian-cell bioreactor in the company's Japanese operations in January 2025. Domestic manufacturing of biopharmaceuticals is further supported by the Japanese government's Ministry of Economy, Trade and Industry. Rising capacity increases the need for validated single-use bags and reduces the need for imported systems.

Features of the Global 2D and 3D Single Use Bioprocess Bag Market

  • Market Size Estimates: 2d and 3d single use bioprocess bag market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: 2d and 3d single use bioprocess bag market size by type, application, and region in terms of value ($B).
  • Regional Analysis: 2d and 3d single use bioprocess bag market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the 2d and 3d single use bioprocess bag market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the 2d and 3d single use bioprocess bag market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the 2d and 3d single use bioprocess bag market by type (EVA, ULDPE, and others), application (buffer & culture medium, stock solution storage, intermediate product storage, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global 2D and 3D Single Use Bioprocess Bag Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 EVA: Trends and Forecast (2019-2035)
  • 4.4 ULDPE: Trends and Forecast (2019-2035)
  • 4.5 Others: Trends and Forecast (2019-2035)

5. Global 2D and 3D Single Use Bioprocess Bag Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Buffer & Culture Medium: Trends and Forecast (2019-2035)
  • 5.4 Stock Solution Storage: Trends and Forecast (2019-2035)
  • 5.5 Intermediate Product Storage: Trends and Forecast (2019-2035)
  • 5.6 Others: Trends and Forecast (2019-2035)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global 2D and 3D Single Use Bioprocess Bag Market by Region

7. North American 2D and 3D Single Use Bioprocess Bag Market

  • 7.1 Overview
  • 7.2 North American 2D and 3D Single Use Bioprocess Bag Market by Type
  • 7.3 North American 2D and 3D Single Use Bioprocess Bag Market by Application
  • 7.4 United States 2D and 3D Single Use Bioprocess Bag Market
  • 7.5 Mexican 2D and 3D Single Use Bioprocess Bag Market
  • 7.6 Canadian 2D and 3D Single Use Bioprocess Bag Market

8. European 2D and 3D Single Use Bioprocess Bag Market

  • 8.1 Overview
  • 8.2 European 2D and 3D Single Use Bioprocess Bag Market by Type
  • 8.3 European 2D and 3D Single Use Bioprocess Bag Market by Application
  • 8.4 German 2D and 3D Single Use Bioprocess Bag Market
  • 8.5 French 2D and 3D Single Use Bioprocess Bag Market
  • 8.6 Spanish 2D and 3D Single Use Bioprocess Bag Market
  • 8.7 Italian 2D and 3D Single Use Bioprocess Bag Market
  • 8.8 United Kingdom 2D and 3D Single Use Bioprocess Bag Market

9. APAC 2D and 3D Single Use Bioprocess Bag Market

  • 9.1 Overview
  • 9.2 APAC 2D and 3D Single Use Bioprocess Bag Market by Type
  • 9.3 APAC 2D and 3D Single Use Bioprocess Bag Market by Application
  • 9.4 Japanese 2D and 3D Single Use Bioprocess Bag Market
  • 9.5 Indian 2D and 3D Single Use Bioprocess Bag Market
  • 9.6 Chinese 2D and 3D Single Use Bioprocess Bag Market
  • 9.7 South Korean 2D and 3D Single Use Bioprocess Bag Market
  • 9.8 Indonesian 2D and 3D Single Use Bioprocess Bag Market

10. ROW 2D and 3D Single Use Bioprocess Bag Market

  • 10.1 Overview
  • 10.2 ROW 2D and 3D Single Use Bioprocess Bag Market by Type
  • 10.3 ROW 2D and 3D Single Use Bioprocess Bag Market by Application
  • 10.4 Middle Eastern 2D and 3D Single Use Bioprocess Bag Market
  • 10.5 South American 2D and 3D Single Use Bioprocess Bag Market
  • 10.6 African 2D and 3D Single Use Bioprocess Bag Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global 2D and 3D Single Use Bioprocess Bag Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Cytiva
    • Company Overview
    • 2D and 3D Single Use Bioprocess Bag Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 CellBios
    • Company Overview
    • 2D and 3D Single Use Bioprocess Bag Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Entegris
    • Company Overview
    • 2D and 3D Single Use Bioprocess Bag Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Saint-Gobain Life Sciences
    • Company Overview
    • 2D and 3D Single Use Bioprocess Bag Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Sentinel
    • Company Overview
    • 2D and 3D Single Use Bioprocess Bag Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 LePure Biotech
    • Company Overview
    • 2D and 3D Single Use Bioprocess Bag Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Cobetter
    • Company Overview
    • 2D and 3D Single Use Bioprocess Bag Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Tofflon
    • Company Overview
    • 2D and 3D Single Use Bioprocess Bag Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Sartorius
    • Company Overview
    • 2D and 3D Single Use Bioprocess Bag Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Biolink
    • Company Overview
    • 2D and 3D Single Use Bioprocess Bag Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global 2D and 3D Single Use Bioprocess Bag Market
  • Figure 2.1: Usage of 2D and 3D Single Use Bioprocess Bag Market
  • Figure 2.2: Classification of the Global 2D and 3D Single Use Bioprocess Bag Market
  • Figure 2.3: Supply Chain of the Global 2D and 3D Single Use Bioprocess Bag Market
  • Figure 3.1: Driver and Challenges of the 2D and 3D Single Use Bioprocess Bag Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global 2D and 3D Single Use Bioprocess Bag Market by Type in 2019, 2026, and 2035
  • Figure 4.2: Trends of the Global 2D and 3D Single Use Bioprocess Bag Market ($B) by Type
  • Figure 4.3: Forecast for the Global 2D and 3D Single Use Bioprocess Bag Market ($B) by Type
  • Figure 4.4: Trends and Forecast for EVA in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Figure 4.5: Trends and Forecast for ULDPE in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Figure 4.6: Trends and Forecast for Others in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Figure 5.1: Global 2D and 3D Single Use Bioprocess Bag Market by Application in 2019, 2026, and 2035
  • Figure 5.2: Trends of the Global 2D and 3D Single Use Bioprocess Bag Market ($B) by Application
  • Figure 5.3: Forecast for the Global 2D and 3D Single Use Bioprocess Bag Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Buffer & Culture Medium in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Stock Solution Storage in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Intermediate Product Storage in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Figure 5.7: Trends and Forecast for Others in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Figure 6.1: Trends of the Global 2D and 3D Single Use Bioprocess Bag Market ($B) by Region (2019-2026)
  • Figure 6.2: Forecast for the Global 2D and 3D Single Use Bioprocess Bag Market ($B) by Region (2027-2035)
  • Figure 7.1: North American 2D and 3D Single Use Bioprocess Bag Market by Type in 2019, 2026, and 2035
  • Figure 7.2: Trends of the North American 2D and 3D Single Use Bioprocess Bag Market ($B) by Type (2019-2026)
  • Figure 7.3: Forecast for the North American 2D and 3D Single Use Bioprocess Bag Market ($B) by Type (2027-2035)
  • Figure 7.4: North American 2D and 3D Single Use Bioprocess Bag Market by Application in 2019, 2026, and 2035
  • Figure 7.5: Trends of the North American 2D and 3D Single Use Bioprocess Bag Market ($B) by Application (2019-2026)
  • Figure 7.6: Forecast for the North American 2D and 3D Single Use Bioprocess Bag Market ($B) by Application (2027-2035)
  • Figure 7.7: Trends and Forecast for the United States 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 7.8: Trends and Forecast for the Mexican 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Canadian 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 8.1: European 2D and 3D Single Use Bioprocess Bag Market by Type in 2019, 2026, and 2035
  • Figure 8.2: Trends of the European 2D and 3D Single Use Bioprocess Bag Market ($B) by Type (2019-2026)
  • Figure 8.3: Forecast for the European 2D and 3D Single Use Bioprocess Bag Market ($B) by Type (2027-2035)
  • Figure 8.4: European 2D and 3D Single Use Bioprocess Bag Market by Application in 2019, 2026, and 2035
  • Figure 8.5: Trends of the European 2D and 3D Single Use Bioprocess Bag Market ($B) by Application (2019-2026)
  • Figure 8.6: Forecast for the European 2D and 3D Single Use Bioprocess Bag Market ($B) by Application (2027-2035)
  • Figure 8.7: Trends and Forecast for the German 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 8.8: Trends and Forecast for the French 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the Spanish 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Italian 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the United Kingdom 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 9.1: APAC 2D and 3D Single Use Bioprocess Bag Market by Type in 2019, 2026, and 2035
  • Figure 9.2: Trends of the APAC 2D and 3D Single Use Bioprocess Bag Market ($B) by Type (2019-2026)
  • Figure 9.3: Forecast for the APAC 2D and 3D Single Use Bioprocess Bag Market ($B) by Type (2027-2035)
  • Figure 9.4: APAC 2D and 3D Single Use Bioprocess Bag Market by Application in 2019, 2026, and 2035
  • Figure 9.5: Trends of the APAC 2D and 3D Single Use Bioprocess Bag Market ($B) by Application (2019-2026)
  • Figure 9.6: Forecast for the APAC 2D and 3D Single Use Bioprocess Bag Market ($B) by Application (2027-2035)
  • Figure 9.7: Trends and Forecast for the Japanese 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 9.8: Trends and Forecast for the Indian 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Chinese 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the South Korean 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the Indonesian 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 10.1: ROW 2D and 3D Single Use Bioprocess Bag Market by Type in 2019, 2026, and 2035
  • Figure 10.2: Trends of the ROW 2D and 3D Single Use Bioprocess Bag Market ($B) by Type (2019-2026)
  • Figure 10.3: Forecast for the ROW 2D and 3D Single Use Bioprocess Bag Market ($B) by Type (2027-2035)
  • Figure 10.4: ROW 2D and 3D Single Use Bioprocess Bag Market by Application in 2019, 2026, and 2035
  • Figure 10.5: Trends of the ROW 2D and 3D Single Use Bioprocess Bag Market ($B) by Application (2019-2026)
  • Figure 10.6: Forecast for the ROW 2D and 3D Single Use Bioprocess Bag Market ($B) by Application (2027-2035)
  • Figure 10.7: Trends and Forecast for the Middle Eastern 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 10.8: Trends and Forecast for the South American 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the African 2D and 3D Single Use Bioprocess Bag Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global 2D and 3D Single Use Bioprocess Bag Market
  • Figure 11.2: Market Share (%) of Top Players in the Global 2D and 3D Single Use Bioprocess Bag Market (2026)
  • Figure 12.1: Growth Opportunities for the Global 2D and 3D Single Use Bioprocess Bag Market by Type
  • Figure 12.2: Growth Opportunities for the Global 2D and 3D Single Use Bioprocess Bag Market by Application
  • Figure 12.3: Growth Opportunities for the Global 2D and 3D Single Use Bioprocess Bag Market by Region
  • Figure 12.4: Emerging Trends in the Global 2D and 3D Single Use Bioprocess Bag Market

List of Tables

  • Table 1.1: Growth Rate (%, 2025-2026) and CAGR (%, 2027-2035) of the 2D and 3D Single Use Bioprocess Bag Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the 2D and 3D Single Use Bioprocess Bag Market by Region
  • Table 1.3: Global 2D and 3D Single Use Bioprocess Bag Market Parameters and Attributes
  • Table 3.1: Trends of the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 3.2: Forecast for the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 4.1: Attractiveness Analysis for the Global 2D and 3D Single Use Bioprocess Bag Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 4.3: Market Size and CAGR of Various Type in the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 4.4: Trends of EVA in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 4.5: Forecast for EVA in the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 4.6: Trends of ULDPE in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 4.7: Forecast for ULDPE in the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 4.8: Trends of Others in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 4.9: Forecast for Others in the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 5.1: Attractiveness Analysis for the Global 2D and 3D Single Use Bioprocess Bag Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 5.3: Market Size and CAGR of Various Application in the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 5.4: Trends of Buffer & Culture Medium in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 5.5: Forecast for Buffer & Culture Medium in the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 5.6: Trends of Stock Solution Storage in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 5.7: Forecast for Stock Solution Storage in the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 5.8: Trends of Intermediate Product Storage in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 5.9: Forecast for Intermediate Product Storage in the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 5.10: Trends of Others in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 5.11: Forecast for Others in the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 7.1: Trends of the North American 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 7.2: Forecast for the North American 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 7.4: Market Size and CAGR of Various Type in the North American 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 7.6: Market Size and CAGR of Various Application in the North American 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 7.7: Trends and Forecast for the United States 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 8.1: Trends of the European 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 8.2: Forecast for the European 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 8.4: Market Size and CAGR of Various Type in the European 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 8.6: Market Size and CAGR of Various Application in the European 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 8.7: Trends and Forecast for the German 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 9.1: Trends of the APAC 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 9.2: Forecast for the APAC 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 9.7: Trends and Forecast for the Japanese 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 10.1: Trends of the ROW 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 10.2: Forecast for the ROW 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW 2D and 3D Single Use Bioprocess Bag Market (2019-2026)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW 2D and 3D Single Use Bioprocess Bag Market (2027-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African 2D and 3D Single Use Bioprocess Bag Market (2019-2035)
  • Table 11.1: Product Mapping of 2D and 3D Single Use Bioprocess Bag Suppliers Based on Segments
  • Table 11.2: Operational Integration of 2D and 3D Single Use Bioprocess Bag Manufacturers
  • Table 11.3: Rankings of Suppliers Based on 2D and 3D Single Use Bioprocess Bag Revenue
  • Table 12.1: New Product Launches by Major 2D and 3D Single Use Bioprocess Bag Producers (2019-2026)
  • Table 12.2: Certification Acquired by Major Competitor in the Global 2D and 3D Single Use Bioprocess Bag Market